Abstract. The effect of cyproheptadine on growth hormone (GH) and prolactin (Prl) 
the incubation media, GH secretion was consistently inhibited and a dose-response relationship was observed between the cyproheptadine concentrations and the amounts of GH released into the media. In (Bivens et al. 1973; Smythe 8c The effect of serotonergic antagonists on GH secretion in acromegalie patients, on the other hand, has not been extensively studied and is controversial. Methergoline was shown to decrease plasma GH contentrations in patients with acro¬ megaly (Chiodini et al. 1976; Delitala et al. 1976) , although this effect of methergoline may have been occasioned via its intrinsic dopamine agonist acti¬ vity (Chiodini et al. 1976) . In a limited number of acromegalie patients, the inhibitory effect of cypro¬ heptadine on GH secretion was demonstrated (Feldman et al. 1976; Kato et al. 1983) (Ishibashi & Yamaji 1981 , 1984 (Ishibashi & Yamaji 1984 (Ishibashi 8c Yamaji 1984; Yamaji 1974 Fig. 1 ). In three pituitary adeno¬ mas which concurrently secreted Prl into the incu¬ bation media (Nos. 1, 2 and 8 in Fig. 1 Fig. 1 ). In Fig. 2 Fig. 2) . Similarly, cyproheptadine inhibited Prl secretion, which was not reversed by coincubation with equimolar serotonin in one ex¬ periment (No. 8 in Fig. 2 (Ishibashi & Yamaji 1978 , 1984 , which can be blocked by equimolar haloperidol (Ishibashi & Yamaji 1984) . In order to exclude the possibility that the observed effect of cyproheptadine on GH and Prl secretion was mediated by the dopaminer¬ gic mechanism, the cells were coincubated with cyproheptadine and haloperidol (Fig. 3) . In all of the experiments conducted using pituitary ade¬ noma cells taken from 3 patients, GH and Prl secretion were significantly inhibited by 0.1 or 1 µ cyproheptadine. Coincubation of the cells with haloperidol, a non-selective dopaminergic antagonist, was without effect of the inhibitory action produced by cryproheptadine. Fig. 4 illustrates the effects of cyproheptadine and dopamine alone or in combination on GH secretion from cultured pituitary adenoma cells of acromegaly. In both experiments, the addition of cyproheptadine or dopamine to the incubation media resulted in a significant decrease in GH secretion. When coincubated with dopamine, cy¬ proheptadine further decreased GH secretion rates.
Discussion
The foregoing results clearly show that cyprohep¬ tadine directly acts on pituitary adenoma cells of acromegaly to suppress GH secretion. The effect Lamberts & MacLeod (1978) reported that cyproheptadinemediated inhibition of in vitro synthesis and release of Prl by rat pituitary cells was occasioned by a non-serotonin-linked mechanism. Desmethylcyproheptadine, a metabolite of cyproheptadine which is neither a serotonin nor a histamine anta¬ gonist (Rickert & Fischer 1975) , was shown to suppress the in vitro release of bioassayable ACTH from the neurointermediate lobe, but not from the anterior lobe of the rat pituitary gland (Lamberts et al. 1983 ). In human corticotroph adenoma cells, the effect of cyproheptadine on ACTH release was inhibited by the addition of serotonin (Ishibashi & Yamaji 1981 (Richardson et al. 1975 
